Detected ·
Captain T Cell
——
Captain T Cell, a spin-off from Max Delbrück Center Berlin developing genetically optimized T-cell therapies for solid tumors, has secured €20M in total funding to advance toward their first clinical trial in 2027 at Charité Berlin and eight other leading German cancer centers.
- Website
- www.captaintcell.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-16 08:04:23 UTC
- Signal ID
- ea0aefe3-5c81-4284-9f25-149693051bd3
As the API returns it
{
"id": "ea0aefe3-5c81-4284-9f25-149693051bd3",
"created_at": "2026-06-16T08:04:23.814995Z",
"company_name": "Captain T Cell",
"company_website_url": "www.captaintcell.com",
"company_linkedin_url": "https://www.linkedin.com/company/captain-t-cell",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Captain T Cell, a spin-off from Max Delbrück Center Berlin developing genetically optimized T-cell therapies for solid tumors, has secured €20M in total funding to advance toward their first clinical trial in 2027 at Charité Berlin and eight other leading German cancer centers.*"
}